Evidence map›Paper›PMID 41294413›Full record

ArticleBiomimetics (Basel, Switzerland)2025

A Boron-Based Topical Strategy for Enhancing Flap Survival: Mechanistic Insights Through Proteomic Analysis.

Cafer Yildirim, Merve Gulsen Bal Albayrak, Sevinc Yanar, Nihal Kayir, Ayse Hande Yozgat, Sevim Aydin, Fikrettin Şahin

Abstract read
In one paragraph

Article in Biomimetics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Histological Evaluation ofBiomedicines · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cafer YildirimDepartment of Basic Medical Sciences, Faculty of Dentistry, Ankara University, Ankara 06560, Turkey.
Merve Gulsen Bal AlbayrakDepartment of Medical Biology, Faculty of Medicine, Kocaeli University, Kocaeli 41001, Turkey.ORCID 0000-0003-2444-4258
Sevinc YanarDepartment of Medical Biology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara 06560, Turkey.ORCID 0000-0002-6438-7385
Nihal KayirDepartment of Medical Pharmacology, Faculty of Medicine, Medipol University, İstanbul 34820, Turkey.
Ayse Hande YozgatDepartment of Histology and Embryology, Faculty of Medicine, Ankara University, Ankara 06560, Turkey.
Sevim AydinDepartment of Histology and Embryology, Faculty of Medicine, Ankara University, Ankara 06560, Turkey.
Fikrettin ŞahinDepartment of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul 34758, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flap viability remains a major challenge in reconstructive surgery due to ischemia-reperfusion injury, excessive inflammation, and impaired tissue regeneration. Boron, a trace element with pro-healing and anti-inflammatory properties, has shown therapeutic promise in various wound models; however, its role in flap healing remains unclear. In this study, we aimed to evaluate the therapeutic potential of sodium pentaborate pentahydrate (SPP)-containing hydrogel, a boron compound we developed, for enhancing flap survival and tissue repair. A dorsal random-pattern flap model was established in male Wistar rats, which were treated topically with an SPP-containing formulation twice daily for seven days. Histological changes were evaluated using hematoxylin-eosin and Masson's trichrome staining, and proteomic alterations were analyzed using label-free nanoLC-MS/MS followed by bioinformatics analysis. The treatment significantly improved flap survival (

Indexed as

boronDermobor®, wound healingflap wound modelproteomicsreconstructive surgerysodium pentaborate pentahydrate (SPP)

Identifiers

PMID41294413
PMCPMC12650326

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.